Short Interest in Arteris, Inc. (NASDAQ:AIP) Expands By 26.4%

Arteris, Inc. (NASDAQ:AIPGet Free Report) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 175,800 shares, a growth of 26.4% from the May 31st total of 139,100 shares. Based on an average trading volume of 162,300 shares, the days-to-cover ratio is presently 1.1 days. Approximately 0.8% of the shares of the company are sold short.

Insiders Place Their Bets

In other news, VP Paul L. Alpern sold 11,250 shares of the business’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $6.39, for a total transaction of $71,887.50. Following the transaction, the vice president now directly owns 81,042 shares in the company, valued at approximately $517,858.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, VP Paul L. Alpern sold 11,250 shares of Arteris stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $6.39, for a total transaction of $71,887.50. Following the completion of the transaction, the vice president now directly owns 81,042 shares in the company, valued at approximately $517,858.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Nicholas B. Hawkins sold 10,000 shares of Arteris stock in a transaction on Thursday, April 11th. The stock was sold at an average price of $7.22, for a total transaction of $72,200.00. Following the transaction, the chief financial officer now directly owns 252,896 shares of the company’s stock, valued at $1,825,909.12. The disclosure for this sale can be found here. Over the last three months, insiders have sold 82,140 shares of company stock valued at $620,475. 33.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Arteris

Several institutional investors have recently modified their holdings of the business. Silvercrest Asset Management Group LLC boosted its position in shares of Arteris by 25.2% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 711,903 shares of the company’s stock valued at $5,211,000 after purchasing an additional 143,385 shares in the last quarter. Acuitas Investments LLC boosted its stake in Arteris by 150.3% during the fourth quarter. Acuitas Investments LLC now owns 215,991 shares of the company’s stock worth $1,272,000 after acquiring an additional 129,692 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of Arteris by 28.1% in the 1st quarter. Acadian Asset Management LLC now owns 534,472 shares of the company’s stock valued at $3,911,000 after buying an additional 117,312 shares during the period. Roubaix Capital LLC increased its position in Arteris by 34.5% in the 4th quarter. Roubaix Capital LLC now owns 342,664 shares of the company’s stock valued at $2,018,000 after buying an additional 87,920 shares in the last quarter. Finally, Worth Venture Partners LLC raised its stake in Arteris by 114.3% during the 4th quarter. Worth Venture Partners LLC now owns 109,921 shares of the company’s stock worth $647,000 after buying an additional 58,620 shares during the period. Institutional investors own 64.36% of the company’s stock.

Arteris Trading Down 5.5 %

Shares of Arteris stock opened at $7.10 on Tuesday. The firm’s 50 day moving average is $7.79 and its 200 day moving average is $6.94. The firm has a market capitalization of $273.21 million, a PE ratio of -6.89 and a beta of 1.11. Arteris has a 1 year low of $4.20 and a 1 year high of $9.54. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.11.

Arteris (NASDAQ:AIPGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The company reported ($0.24) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.03. The company had revenue of $12.95 million during the quarter, compared to analysts’ expectations of $12.60 million. Arteris had a negative return on equity of 198.35% and a negative net margin of 69.70%. Equities research analysts forecast that Arteris will post -0.91 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AIP has been the topic of several recent research reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $9.00 target price (down from $11.00) on shares of Arteris in a report on Monday, May 13th. Rosenblatt Securities reiterated a “buy” rating and set a $15.00 target price on shares of Arteris in a research report on Friday, May 3rd. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Arteris has an average rating of “Moderate Buy” and a consensus target price of $13.40.

View Our Latest Research Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.